The X-waiver required to prescribe opioid abuse medications is now gone. But don't expect patients with substance use dependencies to...
Read moreThe CDC unveiled its latest opioid prescribing guidelines. It's decidedly more patient centric, but fails to account for how law...
Read moreHIPAA was designed to protect patient rights. But for victims of gun violence and the advocates who help them, it...
Read moreThe FDA has asked the DOJ for support in issuing its first ever injunction against six vaping manufacturers.
Read moreThe pardoning of federal marijuana convictions may appear to be a step toward the decriminalization of drugs, but there will...
Read moreGiving patients the autonomy to take medications as needed becomes a liability for chronic pain patients taking opioids.
Read moreAlthough new abortion restrictions often allow exceptions based on “medical emergency” or a “life-threatening physical condition,” cancer physicians describe the...
Read moreCalifornia Together, a campaign led by religious and anti-abortion groups, is hoping to persuade voters to reject a ballot measure...
Read moreThe Supreme Court’s unanimous ruling complicates the Department of Justice’s ongoing efforts to hold irresponsible prescribers criminally liable for fueling...
Read moreSummer has come and gone, and one thing is clear: it was the summer of abortion.
Read moreControlled, willful acts of resistance have been a powerful agent of change throughout history. We need it in medicine, now...
Read moreRecent political tensions have put a strain on healthcare. This is nothing new. Throughout history, politics have influenced healthcare and...
Read moreClinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy